Ye Tian
Fortuna: 16 M $ al 31/08/2026
Fortuna: 16 M $ al 31/08/2026
Ye Edward Tian currently holds the positions of Chief Scientific Officer, Executive Director & EVP at IMPACT Therapeutics, Inc. since 2025, and partner at China Broadband Capital Partners LP.
Education history includes a doctorate from Michigan State University conferred in 1992, a graduate degree from the Chinese Academy of Sciences conferred in 1986, and an undergraduate degree from Tsinghua University conferred in 1982.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 8.422.233 ( 2,98 % ) | 16 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Director Técnico/Científico/I+D | 01/06/2014 |
China Broadband Capital Partners LP
China Broadband Capital Partners LP Investment ManagersFinance CBC Capital invests in companies located in China. The firm focuses on companies operating in the fields of technology, media and telecommunication (TMT) industries. It provides financing for buyout capital requirements. | Inversor de Capital Privado | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
China Broadband Capital Partners LP
China Broadband Capital Partners LP Investment ManagersFinance CBC Capital invests in companies located in China. The firm focuses on companies operating in the fields of technology, media and telecommunication (TMT) industries. It provides financing for buyout capital requirements. | Finance |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.